Evaluation of tolerability and anti-tumor activity of GDC-0032, a PI3K inhibitor with enhanced activity against PIK3CA mutant tumors, administered-to patients with advanced solid tumors Meeting Abstract


Authors: Juric, D.; Infante, J. R.; Krop, I. E.; Kurkjian, C.; Patel, M. R.; Graham, R. A.; Wilson, T. R.; Hsu, J. Y.; Baselga, J.; Von Hoff, D. D.
Abstract Title: Evaluation of tolerability and anti-tumor activity of GDC-0032, a PI3K inhibitor with enhanced activity against PIK3CA mutant tumors, administered-to patients with advanced solid tumors
Meeting Title: 17th European Cancer Conference (ECCO 17)
Journal Title: European Journal of Cancer
Volume: 49
Issue: Suppl. 2
Meeting Dates: 2013 Sep 27-Oct 1
Meeting Location: Amsterdam, Netherlands
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2013-09-01
Start Page: S168
Language: English
ACCESSION: WOS:000326843601095
PROVIDER: wos
DOI: 10.1016/S0959-8049(13)70061-3
Notes: Meeting Abstract: 822 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga